Article
Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity.
Cells - 29 Jun 2021
Zapatero-Belinchón Francisco J, Ötjengerdes Rina, Sheldon Julie, Schulte Benjamin, Carriquí-Madroñal Belén, Brogden Graham, Arroyo-Fernández Laura M, Vondran Florian W R, Maasoumy Benjamin, von Hahn Thomas, Gerold Gisa
Abstract excerpt
The HCV replication cycle is tightly associated with host lipid metabolism: Lipoprotein receptors SR-B1 and LDLr promote entry of HCV, replication is associated with the formation of lipid-rich membranous organelles and infectious particle assembly highjacks the very‑low-density lipoprotein (VLDL) secretory pathway. Hence, medications that interfere with the lipid metabolism of the cell, such as statins, may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
